Thanks, Carusso, for asking. After reading the lengthy report by VIVMF, I believe that this company is really serious about becoming the leading medical delivery for women's laxity problems. If so, the stock will reach $10 per share without reverse split.
However, this will take a long time, and the number of headwinds listed in the report is enormous. So, for the near term the reverse split may bring in more new investors after the insiders release their shares for trade. Nothing works better than the bottom line: sales. But stock manipulation is a favorite trick among penny stock companies. Maybe, this won't be a penny stock for long.
I will approve all the provisions in the proxy vote just released, including the reverse split. Let's give this company all the rope they need (hopefully not to hang us out to dry).
Sentiment: Hold until investors' meeting has settled.
News 
Market Data 
Discover 
